Cartilage Degeneration Market Global Analysis & Forecast - 2027

report image

Cartilage Degeneration Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Procedure Type (Osteochondral Transplant, Chondroplasty, Joint Replacement, Meniscus Transplants, Cell-based Cartilage Resurfacing, and Others); Application (Knee, Hips and Others) End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Academic & Research Institutes); and Geography

Publication Month: Aug 2020 | Report Code: TIPMD00002230 | No. of Pages: 169 | Category: Medical Device | Status: Published

The cartilage degeneration market is expected to reach US$ 14,580.10 million in 2027 from US$ 10,459.93 million in 2019. The market is estimated to grow with a CAGR of 4.4% from 2020-2027.

Cartilage plays an important role in smooth mechanical movements of bones and muscles. Degeneration of cartilage can lead to pain and chronic inflammation in joints. Furthermore, this damaged cartilage can potentially influence quality of the life. Continual research and development is leading to innovation of new techniques and methodologies to deal with damages cartilages. Some of these techniques comprises joint replacement, cell therapies, and chondroplasty amongst others.The global cartilage degeneration market is driven by factors such as growing number of sports injuries, and increasing prevalence of obesity. However, the high cost of cartilage repair hampers the market growth. Additionally, growing number of product approvals and developments are creating growth opportunities for the market players.

Lucrative Regional Markets for Cartilage Degeneration



Lucrative Regional Markets for Cartilage Degeneration

Get more information on this report :


Market Insights

Increasing Prevalence of Obesity

Obesity has a considerable effect on the musculoskeletal system, resulting into degeneration of bones, cartilage, and ligaments. Moreover, the condition, along with other prominent factors, is strongly allied with the increased risk of rapid cartilage loss. The growing prevalence of obesity is likely to accelerate the incidence of cartilage degeneration, which will drive the market growth.

According to the study published by the World Health Organization (WHO) in 2020, the frequency of obesity among the worldwide population has tripled since 1975. Furthermore, according to the same study, 38 million children below 5 years of age were overweight in 2019 worldwide. This massive prevalence of obesity is likely to accelerate due to unhealthy lifestyles such as consumption of junk food, sedentary lifestyle, genetic conditions, and deprivation of mental health. For instance, according to a study published by the Centers of Disease Control and Prevention, the prevalence of obesity grew from 30.5% to 42.4% during past two decades in the US. Overweight conditions among players and athletes can lead to the increasing prevalence of sports injuries. For instance, according to a study published in the British Journal of Sports Medicine in 2015, athletes with BMI index more than 30 kg/m2 are highly susceptible generationto the sports injuries. Such association between obesity and cartilage degeneration is anticipated to drive the market growth by 2027.

Application Insights

Based on application, the cartilage degeneration market is segmented into knee, hip, and other applications. In 2019, the knee segment accounted for the highest share of the market. Growth of this segment is attributed to the increasing prevalence of knee injuries. For instance, according to study published on online newspaper, which is based on NCBI data, an estimated 1 in 4 adults suffer from chronic knee pain. Moreover, the prevalence of knee pain has witnessed massive growth of around 40.0% during past 4 decades. Furthermore, increasing awareness of benefits provided by cartilage repair is also anticipated to drive the growth of knee segment.

Global Cartilage degeneration market, by Application– 2018 and 2027



Global Cartilage degeneration market, by Application– 2018 and 2027

Get more information on this report :


Procedure Type Insights

The cartilage degeneration market, by procedure type, is segmented into osteochondral transplant, chondroplasty, joint replacement, meniscus transplants, cell-based cartilage resurfacing, and other procedure types. The joint replacement segment held the largest share of the market in 2019, whereas the cell-based cartilage resurfacing segment is anticipated to register the highest CAGR in the market during the forecast period.

End User Insights

Based on end user, the cartilage degeneration market is segmented into hospitals and specialty clinics, ambulatory surgical centers and,academic & research institutes. The hospitals and specialty clinicssegment held the largest share of the market in 2019. Also, the segment is estimated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Report Coverage - Cartilage Degeneration Market
Report CoverageDetails
Market Size Value inUS$ 10,459.93 Million in 2019
Market Size Value byUS$ 14,580.10 Million by 2027
Growth rateCAGR of 4.4% from 2020-2027
Forecast Period2020-2027
Base Year2020
No. of Pages169
No. of Tables73
No. of Charts & Figures70
Historical data availableYes
Segments coveredProcedure Type ; Application End User ; and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product launches and approvalsare the commonly adopted strategies by companies to expand their global footprintsand product portfoliostomeet the growing consumer demand. The cartilage degeneration marketplayers adopt the collaborationsstrategy to enlarge customer base worldwide, which also permits them to maintain their brand name globally.

Global Cartilage degeneration market– ByProcedure type

  • Osteochondral Transplant
  • Chondroplasty
  • Joint Replacement
  • Meniscus Transplants
  • Cell-based Cartilage Resurfacing
  • Others Procedures

Global Cartilage degeneration market– By Application

  • Knee
  • Hip
  • Other Applications


Global Cartilage degeneration market– By End User

  • Hospitals and Specialty
  • Clinics, Ambulatory Surgical Centres
  • Academic and Research Institutes

Cartilage degeneration market– By Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America

    • Brazil
    • Argentina
    • Rest of South America

Company Profiles

  • Zimmer Biomet
  • CartiHeal Inc.
  • Vericel Corporation
  • Depuy Synthes
  • Anika Therapeutics, Inc.
  • Conmed Corporation
  • Arthrex,Inc.
  • B. Braun Melsungen AG
  • Stryker
  • Smith and Nephew Plc..

Frequently Asked Questions

The major growth driving factors of cartilage degeneration market are increasing number of sports injuries, and growing prevalence of obesity.
Anika Therapeutics Inc., B. Braun Melsungen AG, CartiHeal Inc., Smith and Nephew Plc., Depuy Synthes, Zimmer Biomet, Vericel Corporation, Arthrex Inc., Conmed Corporation, Stryker, amongst others are a number of the leading corporations operational within the cartilage degeneration market.
The cartilage degeneration market is growing at CAGR of 4.4%
Among others, APAC region is growing at CAGR of 5% in cartilage degeneration market
On the basis of end user, the cartilage degeneration market is segmental into hospitals and specialty clinics, ambulant surgical centers and, educational & research institutes. The hospitals and specialty clinics section command the biggest share of the market in 2019.

The List of Companies - Cartilage Degeneration Market

  1. Zimmer Biomet
  2. CartiHeal Inc.
  3. Vericel Corporation
  4. Depuy Synthes
  5. Anika Therapeutics, Inc.
  6. Conmed Corporation
  7. Arthrex,Inc.
  8. B. Braun Melsungen AG
  9. Stryker
  10. Smith and Nephew Plc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cartilage degenerationmarket.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global cartilage degenerationmarket, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPMD00002230
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount